April 29th 2025
Brett Casper explores the marketplace complexities that manufacturers face regularly.
April 16th 2025
The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization.
March 12th 2025
The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.
February 24th 2025
The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara.
January 14th 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Orphan drug commercialization is maturing
Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
Uncertainty around the pediatric priority review voucher (PRV) program
Mylan will create a generic EpiPen, competing against itself
More unusual gyrations as Mylan attempts to quell uprising against its pricing policies
J.D. Power pharmacy satisfaction survey: independents on top in brick-and-mortar
Good Neighbor and Health Mart franchises trade top positions
Mylan’s EpiPen re-energizes drug pricing disputes
Presidential politicking adds momentum to the growing backlash, and not just for Mylan
Big data analytics is a work in progress in pharma
Substantial investments have been made, but beneficial results hard to identify, says ZS Associates
Attaining 'commercial agility' in data management
Life sciences marketers contend with a flood of new data sources—and the challenge of integrating them for meaningful results
MannKind calls on Asembia to assist in relaunch of Afreeza inhalable insulin
Applying specialty-pharma techniques to a potentially mass-market drug
Where are those missing billions in new-product pharma sales?
Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs
Private-capital injection into inVentiv Health reshuffles life sciences outsourcing
Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer
Cardiovascular therapy: More new drugs for a growing patient base
The scale of the cardiovascular market pushes payers to demand quality outcomes data
Patient copays: the growth mechanism of the pharma industry?
Bloomberg BusinessWeek rakes over charitable copay programs
Contract sales cuts for AstraZeneca as Crestor goes off-patent
Dohmen appoints Joe Nolan to president, Dohmen Life Science Services
Company pursues ‘bench to bedside’ commercialization services
Sermo reaches 30 countries to connect physicians in an online community
Site opens up a Facebook-like “Pages” to vendors and medical organizations
2016 EMD Serono Specialty Digest: health plans’ ongoing cost struggle
Managed care organizations are adjusting rapidly to onslaught of specialty products
Oncology: a new era in therapies; same cost concerns
A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor
Changing the payment paradigm
Policymakers look at alternative payment models in oncology
Another tough week for pharma on drug pricing policy
More healthcare stakeholders line up against the industry
Copay assistance data on the iPad: TrialCard’s new app
Integrating copay programs with multichannel marketing
HealthPrize cuts ‘gap days’ in medication non-adherence
Gamifcation software developer touts value of its patient reward system
IMS 2015 Use of Medicines report: US sales reach $424.8 billion
Double-digit growth (12.2%) for the second year running
Another approach to specialty patient support: independent pharmacies
KloudScript seeks to backstop local pharmacies with specialty services
Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute
Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians
ZS Associates sharpens focus on pharma-physician interaction
'Customer Experience Tracker' measures success in oncologist interactions
Reltio captures IT analysts' attention for master data management
Announces a new version of its "platform as a service," with connectivity to Apache Spark
Walgreens and OptumRx partnership: more consolidation in retail pharmacy
Partnership combines mail-order PBM with brick-and-mortar drugstores
Express Scripts 2015 Drug Trend: not so bad in drug price escalation
Annual report highlights company's cost-control measures
New ProPublica analysis correlates physician payments with higher brand prescribing
Ophthamology tops the breakout by physician specialty
QPharma revamps its commercialization/compliance IT suite as Titanium
Sample distribution management, payments reporting and sales-rep training